Bisphosphonate-induced Severe Hypocalcemia - A Case Report

• Published in: Journal of bone metabolism Vol. 19; no. 2; pp. 139 - 145
• Main Authors: Do, Won-Seok, Park, Jin-Kyung, Park, Myung-Il, Kim, Hyeong-Seok, Kim, Sung-Ho, Lee, Duk-Hyun
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Society for Bone and Mineral Research 01.11.2012; 대한골대사학회
• Subjects: Case Report; 정형외과학; Osteoporosis; Bisphosphonates; Hypocalcemia
• ISSN: 2287-6375; 2287-7029
• DOI: 10.11005/jbm.2012.19.2.139

Bisphosphonate generally seems to be safe, but hypocalcemia may occasionally develop in the course of bisphosphonate treatment. Hypocalcemia induced by bisphosphonate is usually mild and asymptomatic, but unrecognized or poorly treated hypocalcemia can lead to life-threatening state. A 78-year-old woman who had a history of hip arthroplasty and intravenous zoledronate treatment for femur neck fracture was presented to emergency department with altered mental status. It turned out that her symptom was due to severe hypocalcemia which was caused by intravenous zoledronate treatment. She also had renal dysfunction. She was treated by intravenous calcium gluconate and calcitriol administration. This case supports the need for evaluation of renal dysfunction, vitamin D deficiency and parathyroid gland dysfunction before bisphosphonate treatment and accurate monitoring of plasma calcium and creatinine levels. In addition, vitamin D and calcium supply during treatment with bisphosphonate is mandatory.